<DOC>
	<DOCNO>NCT00848627</DOCNO>
	<brief_summary>In study propose , 1,500 men age 60 strong smoking history test urine presence blood daily two 10-day test period Ames Hemastix . Individuals even solitary positive test undergo thorough urologic evaluation determine cause hematuria follow-up continue 2 year completion study .</brief_summary>
	<brief_title>Screening Bladder Cancer</brief_title>
	<detailed_description>Reduction cancer mortality state goal National Cancer Institute . Cancer bladder 4th commonly diagnose cancer 7th lead cause cancer death American men , represent important target mortality-reducing effort . Furthermore , tumor , even early ( i.e . curable ) stage , usually cause several easily detectable abnormality , include hematuria , presence abnormal tumor product shed urine lie within exfoliate malignant cell . The overall goal propose study gain information concern performance characteristic three bladder cancer marker combine hematuria test detect bladder cancer . A mail back questionnaire , complete begin study , provide information participant result testing report testing period . Individuals even solitary positive test undergo thorough urologic evaluation determine cause hematuria follow-up continue 2 year completion study . At time evaluation , three bladder cancer marker test , NMP22 Bladder Chek , ImmunoCyt UroVysion FISH perform , regardless result , hematuria evaluation complete . Data update continually . The 10 day test Hemastix repeat 9 month first one complete regardless outcome first testing .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Men age 60 , current cigarette smoker OR history least 20 pack year smoke OR 30 pack/year history stop smoke within 10 year registration date OR 40 pack year history smoking regardless quit date , eligible participation . Patients prostate renal cancer must treat 5 year previously consider diseasefree time entry . In case prostate cancer , patient may receive prostatectomy treatment must undetectable PSA 's study entry . In case calculus disease , patient must believe stone free time study entry could stone attack within previous 2 year . Patients receive anticoagulation therapy , Warfarin , Plavix , Lovenox , aspirin , etc . able take part study , thoroughly workedup explainable cause hematuria receive anticoagulation medication . history urothelial cancer malignancy nonmelanoma skin cancer treat within past 5 year benign tumor urinary tract still existent know urinary calculus medical oncological condition know produce hematuria ( e.g . glomerulonephritis , treatment cyclophosphamide , methotrexate pelvic radiation therapy ) visual , psychological , neurological , musculoskeletal , etc . impairment would make home test impractical</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Bladder cancer</keyword>
	<keyword>Smokers</keyword>
	<keyword>Hematuria</keyword>
</DOC>